Category: Synthes Inc.
Johnson & Johnson's Synthes subsidiary warns of the risk that 1 of its soft tissue retractors might fragment during use.
Hong Kong's Medical Device Control Office said Johnson & Johnson's (NYSE:JNJ) Synthes division issued a warning about the risk of injury from 1 of its soft tissue retractors.
Wall Street analysts worry that there may be larger negative trends for the industry as Johnson & Johnson reports declines in some of its medical device businesses.
Healthcare titan Johnson & Johnson (NYSE:JNJ) scored some hits and misses with Wall Street upon releasing its 1st-quarter 2013 earnings report, touting a 10% overall increase in medical devices and diagnostics revenues but failing to thrill analysts.
A comparison of asset values and share values for medical device companies from the MassDevice Big 100 database.
One way to assess stock values is to compare the stock's share price with its asset value.
The latter is the number of shares outstanding divided into total assets. When the result is compared with share prices, it can help investors decide whether a stock is over- or under-valued.
We took a look at the asset values for 15 of the world's largest pure-play medical device companies and then compared them with the companies' stock price.
A look at how the 15 largest medical device companies boosted (or cut) their workforces last year, from the MassDevice Big 100 database.
The economic recovery has been slow going in the U.S. as the housing market and persistently high unemployment have proven particularly stubborn.
That's why we were surprised, after looking at the employment numbers in our MassDevice Big 100 database, to find that only 3 of the largest 15 med-tech makers wound up cutting their global workforces last year.
Newly acquired Synthes recalls its Hemostatic Bone Putty over concerns that the product may "ignite" if it comes into contact with certain surgical devices.
Newly acquired Synthes Inc. recalled certain lots of its Hemostatic Bone Putty over concerns that the product may catch on fire in certain conditions.
The product, which is used to stop bone bleeding by establishing a physical barrier along the edges of bones, should be returned to Synthes, according to the FDA notice.
Despite a lethargic economy, medical device companies boosted their spending on research & development last year, according to MassDevice.com's Big 100 database of the 100 largest med-tech makers.
Across the medical device industry, R&D spending in 2011 increased despite a lethargic economy, job cuts and reorganization mandates by a number of big-name companies.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com's coverage highlights our seven biggest and most influential stories from the week's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you're still in the know with MassDevice +7.
